[RO in PR Newswire] Ro announces agreement with the NIH National Institute on Aging (NIA) to diversify clinical trial registration using its telehealth platform

NEW YORK, Oct. 6, 2022 /PRNewswire/ — Ro, the leading direct-to-patient healthcare company, today, announced an agreement with the National Institute on Aging (NIA), part of the National Institutes of Health (NIH), to create the “Registry for Equal Access to Clinical Trials in Alzheimer’s Disease (AD)” (REACT-AD).

Read more here.